WebTheir technology is effective for the exploration of compounds against drug targets that cannot be handled by conventional high-throughput screening technologies and the … WebOperating Status Active. Last Funding Type Seed. Also Known As 株式会社. Legal Name SEEDSUPPLY INC. Company Type For Profit. SEEDSUPPLY research and develops medical and agricultural chemical products. The company is a spin-off of Takeda Pharmaceutical Company Limited and established in May 2024 and is headquartered in Fujisawa, …
The Seed Supply The Seed Supply - Organic Soil Nutrition
WebOct 28, 2024 · Elix will incorporate SEEDSUPPLY's wealth of data, particularly its data on key drug discovery targets such as membrane proteins, into the AI's training pipeline, thereby advancing technology for ... WebAbout us. Dr. Tarui has been involved in drug discovery research especially hit finding for 20 years at Takeda Pharmaceutical Company. A typical hit compound is the seed compound of vonoprazan (the world's first potassium competitive acid blocker). Dr. Tarui has established SEEDSUPPLY as spin-out from Takeda in 2024 to improve the early drug ... burgundy leather desk pad
tenants-voice-seedsupply
WebOct 7, 2024 · 武田薬品工業のEntrepreneurship Venture Program(EVP)は、SPARKとは異なるアプローチでバイオベンチャーを創出します。 ... 1年かけて準備したところ、31件の申請があり、SEEDSUPPLYを含む9件のプロジェクトがEVPで立ち上がりました。 ... WebInformation on valuation, funding, cap tables, investors, and executives for SEEDSUPPLY. Use the PitchBook Platform to explore the full profile. WebINTERVIEW (「reboot」ー武田薬品を離れた人々の現在地①) インタビュー・株式会社SEEDSUPPLY社長 樽井直樹 世界の医薬品業界 (第193回) burgundy leather recliner with nail heads